Dilated cardiomyopathy (DCM) is a common heritable cardiomyopathy with substantial clinical and genetic heterogeneity (≈1 in 200). Determining whether a patient carries a likely pathogenic/pathogenic (LP/P) variant is clinically important since genotype status is associated with differences in disease course and...
F. El Kayouhi, L. Arts, F. Raijmakers et al.· European Heart Journal· 0 citations
The HFA-PEFF and H2FPEF scores based on automated and manual echocardiographic analysis showed similar diagnostic accuracy, suggesting automated HFpEF diagnosis using deep learning analysis of echocardiograms is feasible.
C. Venema, M. Venner, A. Achten et al.· European Heart Journal - Dig...· 1 citation
BACKGROUND
Cardiomyopathy guidelines recommend routine screening of at-risk relatives with dilated cardiomyopathy (DCM). Titin-truncating variants are the most prevalent cause. However, the diagnostic yield of screening is low. Risk-based stratification could optimize screening intervals and resource allocation. This s...
S. Muller, N. Beelen, A. Paldino et al.· Circulation: Heart Failure· 0 citations
BACKGROUND
Atrial fibrillation (AF) is the most common arrhythmia in dilated cardiomyopathy (DCM) and is associated with adverse outcomes. However, the genetic determinants of AF risk and its prognostic significance across genotyped DCM subtypes remain unknown.
METHODS
In this observational cohort study, we analyzed...
I. Balakrishnan, A. Heymans, B. Claggett et al.· Circulation: Heart Failure· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.